Mankind Pharma, a domestic-focused Indian pharmaceutical company is looking for selective acquisition opportunities that add value to its portfolio. The company will focus on the chronic and consumer segments, concentrating on its chronic side while consolidating its OTC offerings. With a strong balance sheet, the company plans to utilize any extra funds generated from its organic growth for acquisitions, but only if the prices are reasonable and if the acquisition adds value to its existing portfolio.